Processes | Free Full-Text | Cancer Stem Cell Microenvironment Models with Biomaterial Scaffolds In Vitro | HTML
Cancer stem cells, stemness markers and selected drug targeting: metastatic colorectal cancer and cyclooxygenase-2/prostaglandin E2 connection to WNT as a model system
Frontiers | Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies | Immunology
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications: Molecular Therapy - Oncolytics
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
Cancers | Free Full-Text | Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight | HTML
Expression of Putative Cancer Stem Cell Markers in NSCLC Cell Lines. | Download Table
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis: Cell
Frontiers | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts | Oncology
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
The key roles of cancer stem cell-derived extracellular vesicles | Signal Transduction and Targeted Therapy
Lung cancer stem cells: tools and targets to fight lung cancer | Oncogene
Transitional dynamics of cancer stem cells in invasion and metastasis - ScienceDirect
Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence | Therapeutic Delivery
Frontiers | Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies | Immunology
Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer: Cell
Cancer Stem Cell Biomarkers in EGFR-Mutation–Positive Non–Small-Cell Lung Cancer - Clinical Lung Cancer
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
3D modeling of cancer stem cell niche | Oncotarget
